Skeletal Muscle Loss during Tyrosine Kinase Inhibitor Treatment for Advanced Hepatocellular Carcinoma Patients

INTRODUCTION: The measurement of body composition such as the skeletal muscle index (SMI) has been reported to be useful for predicting prognosis in hepatocellular carcinoma (HCC). In this study, we analyzed skeletal muscle change during sorafenib and lenvatinib therapy and the association between S...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Liver Cancer
Prif Awduron: Uchikawa, Shinsuke, Kawaoka, Tomokazu, Namba, Maiko, Kodama, Kenichiro, Ohya, Kazuki, Morio, Kei, Nakahara, Takashi, Murakami, Eisuke, Tsuge, Masataka, Hiramatsu, Akira, Imamura, Michio, Takahashi, Shoichi, Chayama, Kazuaki, Aikata, Hiroshi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: S. Karger AG 2020
Pynciau:
Original Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206610/
https://ncbi.nlm.nih.gov/pubmed/32399429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503829
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg